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SUMMARY – As mental and psychological issues are important in the development of many 
dermatologic diseases, these factors are of special interest in research. Psychoneuroimmunology is 
the study of interaction between psychological processes and the nervous and immune systems of 
the human body, and it was comprehensively described for the first time about 30 years ago. Co-
mmunication between the mind and the skin involves the psycho-immuno-endocrine-cutaneous 
system, encompassing the activities of the brain, the immune system and the skin, with participation 
of different neuropeptides, interleukins, and immune system messengers. Many common dermato-
logic diseases have some form of psychomediated pathogenesis that partially accounts for the deve-
lopment of skin lesions. There is a link between emotional stressors (acute or chronic), psychiatric 
diseases, and dermatoses (e.g., psoriasis, atopic dermatitis, urticaria, viral warts, herpes simplex, 
vitiligo, acnes, alopecia, prurigo, etc.) and different cytokines and mediators produced in the skin 
and involved in their pathogenesis. A prominent role is played by those agents that belong to the 
hypothalamic-pituitary-adrenal axis. 
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Introduction
Mental and psychological issues are important in 
the genesis and development of many diseases, includ-
ing different dermatoses1. Psychoneuroimmunology 
encompasses the interaction of the nervous system and 
immunity, being for the first time comprehensively de-
scribed about 30 years ago, although the influence of 
mental status on the course and outcome of numerous 
diseases had been suspected long before1-4. The pri-
mary route of communication between the mind and 
the body is the psycho-immuno-endocrine-cutaneous 
system, connecting the activity of the brain, the im-
mune system, and the skin. This communication in-
volves different neuropeptides, interleukins, immune 
system messengers, hormones, etc. There is clinical 
and experimental evidence that the brain can start, af-
fect, and halt biological skin events and that the skin, 
as a relevant part of the ‘diffuse brain’, can modify the 
quality of perceptions and feelings. 
Many common dermatologic diseases have some 
form of psychomediated pathogenesis that partially 
accounts for the development of lesions. Clinical ob-
servations support a link between emotional stressors 
(acute or chronic), psychiatric diseases, and many der-
matoses and also report positive effects of psychop-
harmacology and psychotherapy in their treatment. 
Thus, different dermatoses can be associated with 
some psychomediated mechanism, e.g., psoriasis, 
atopic dermatitis (AD), urticaria, viral warts, herpes 
338 Acta Clin Croat,  Vol. 52,   No. 3,  2013
Liborija Lugović-Mihić et al. Psychoneuroimmunologic aspects of skin diseases
simplex, vitiligo, acnes, hyperhidrosis, effluvium, alo-
pecia, idiopathic itch, lichen simplex, rosacea, sebor-
rheic dermatitis, etc.1.
The main neuroendocrine and nervous pathways 
of carrying out the physiological effect of psychologi-
cal, biological, and social factors on the immunity and 
disease development are the hypothalamic-pituitary-
adrenal axis (HPA axis) and the sympathetic, ad-
renomedullary, and parasympathetic systems2. These 
systems react to stressogenic stimuli and can cause 
pathological occurrences in acute or chronic stress. It 
is significant that stress resistance can be enhanced 
by personal coping mechanisms, social support, and 
favorable psychosocial constellations. 
According to the biopsychosocial model, psycho-
social factors interact with the person’s biological char-
acteristics (e.g., genetic or constitutional) engendering 
vulnerability to disease processes5. Thus, genetic pre-
disposition to disease development (‘diathesis’) may 
remain latent until stress events, represented as an in-
teraction between the biopsychosocial factors and the 
person’s biology2. Psychological and social factors are 
believed to influence disease processes via two main 
mechanisms: psychosocial processes (e.g., mental 
health and mood factors, personality characteristics, 
resources, social relationships) and health-oriented 
behaviors (e.g., hygiene, protective measures such as 
sun protection, exercise, nutrition, smoking)2,6.
Studies have shown the association between illness, 
behavior and psychological state (anxiety, depression, 
sleep loss, bereavement, etc.) and certain external 
stress factors (e.g., family illness, academic stress, un-
employment), which seem to affect the immune sys-
tem in some way4,7. As data on personality and coping 
suggest, differences in perceptions and reactions to the 
same events can provoke different endocrine and im-
mune responses. In fact, neuroendocrine mechanisms 
may mediate the associations between personality and 
coping styles and immune function2,8.
When talking about the skin, the neuroendocrine 
substances originate from nerve fibers that innervate 
it, or from skin cells that can produce and secrete hu-
moral signal molecules (neurotransmitters, neuropep-
tides and hormones), which enter the HPA axis and 
are analogous to its own neurotransmitters, neuropep-
tides and hormones2. Neuromediators in the skin also 
include classical neurotransmitters (catecholamines 
and acetylcholine), released from autonomous nerve 
fiber endings in the skin and skin cells. Skin protei-
nases also have a regulatory role in immune and in-
flammatory reactions, acting as enzymes or ligands 
of specific receptors (proteinase-activated receptor, 
PAR). 
It is important that there is also evidence that at 
the local level (in the skin) a neuroendocrine control 
mechanism exists, similar to the central one that acts 
at the level of the whole body. 
Cellular Elements of the Skin Immune System and 
Cytokine Secretion 
In the epidermis and dermis, there are vari-
ous immune cells [keratinocytes, dermal dendritic 
cells (DCs), epidermal Langerhans cells (LSs), mel-
anocytes, T cells and others], which reach the skin 
through recirculation2. So, when stimulated, skin cells 
(primarily keratinocytes) produce various cytokines. 
Although keratinocytes of healthy skin do not express 
class II major histocompatibility complex (MHC-IL) 
or adhesion molecules ICAM-l (an important com-
ponent for antigen presentation), it is possible in some 
skin diseases (acting as accessory cells that stimulate 
proliferation of antigen-stimulated T cells)2. 
Keratinocytes synthesize various chemokines and 
cytokines that act through corresponding receptors on 
skin cells, having numerous effects on the migration of 
inflammatory cells, proliferation and differentiation of 
keratinocytes, synthesis of other cytokines, and on the 
immune system. After skin contact with the antigen, 
keratinocytes are activated and produce and secrete 
various cytokines and chemokines, through which 
they regulate inflammatory and immune reactions in 
the skin. Activated keratinocytes secrete proinflam-
matory cytokines (IL-1α, IL-6, IFN-γ), which en-
hance migratory activity of LCs leaving for regional 
lymph nodes, where they stimulate proliferation of 
specific T cells9. Thus, keratinocytes can have a role 
of accessory cells for antigen presentation (under the 
influence of proinflammatory cytokine IFN-γ they 
express MHC-lI). Specific T cells enter the circula-
tion and, attracted by chemokines, arrive in the skin 
where they remain due to increased expression of ad-
hesion molecules on endothelial cells of dermal blood 
vessels. After initial stimulation of inflammatory and 
immune reactions, they are inhibited to preserve ho-
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meostasis [keratinocytes participate by secreting an-
tiinflammatory cytokines IL-10 and transforming 
growth factor-β (TGF-β)]2,9. 
Keratinocytes produce IL-1 and IL-6 whose basal 
synthesis is enhanced by some allergens or superan-
tigens. IL-1 is stored in the skin (predominantly as 
IL-1α) and probably waits to act immediately after an 
injury or bionoxa. So, IL-1α induces several genes in 
skin cells, including keratinocytes, fibroblasts (FBLs) 
and endothelial cells of blood vessels, e.g., genes for 
adhesion molecules, chemokines, cytokines, prote-
olytic enzymes and matrix proteins. Keratinocytes 
also produce IL-6, which stimulates keratinocyte pro-
liferation and it is important in different pathologic 
conditions (e.g., psoriasis, lichen planus, wound heal-
ing), after exposure to UV radiation or after treatment 
with tumor necrosis factor (TNF-α)2. 
Keratinocytes also produce immunomodulatory 
cytokines that have systemic effects, IL-10 and IL-12, 
and act antagonistically. After exposure to UV radia-
tion, immunosuppression occurs for which keratino-
cyte IL-10 is responsible because it shifts the cytokine 
profile from T helper type 1 (Th1) to T helper type 2 
(Th2) cell type (suppresses cellular immunoreaction). 
On the other hand, IL-12 has an important role in 
Th1 response induction. It was found that allergens 
stimulate keratinocytes to secrete IL-12, as in aller-
gic contact dermatitis (as opposed to irritant contact 
dermatitis). Recently, it has been shown that keratino-
cytes secrete IL-18, a key mediator that induces Th1 
response (e.g., in AD). 
It is significant that keratinocytes synthesize growth 
factor and chemokines (IL-8, TNF-α). Chemokines 
are small cytokines which, during inflammation, are 
involved in chemotaxis, cell migration and activation, 
especially of phagocytes and lymphocytes. Thereby, 
IL-8 is a chemotactic factor for neutrophils and is se-
creted after contact with various irritants and in auto-
immune skin diseases, while TNF-α is released after 
UV radiation (when it induces keratinocyte apoptosis) 
and in some skin diseases (e.g., psoriasis and skin T-
lymphomas)2. 
The Role of Hypothalamic, Hypophyseal and 
Adrenocortical Hormones 
It has been determined that skin produces hypo-
thalamic and hypophyseal signal peptides, which are 
secreted in the intercellular space. So, epidermal kera-
tinocytes and dermal FBLs synthesize hypothalamic 
and hypophyseal signal peptides and express receptors 
for them2. Thus, the skin synthesizes all peptide hor-
mones that enter the HPA axis (the main mediator in 
stress response), hypothalamic corticotropin-releasing 
hormone (CRH) and urocortin (a peptide similar to 
CRH). CRH is a central component of the HPA 
axis and regulates the expression of pro-opiomelano-
cortin (POMC) and pituitary POMC-derived pep-
tides [(ACTH, α-melanocyte-stimulating hormone 
(α-MSH) and β-endorphin)] (from the anterior pitu-
itary gland)10. 
The skin is directly exposed to various environ-
mental stressors (UV radiation, pathogens, thermal 
and chemical insults) and the skin cells have devel-
oped a number of defense mechanisms that are coor-
dinated by messages from the local neuroendocrine-
immune system. The predominant skin stressor from 
the environment is sun radiation (particularly the UV 
spectrum) that increases the expression of the gene 
for prostaglandin metabolism and the genes for IL-
1, IL-6, IL-8, IL-10, for some metalloproteinases, 
whilst decreasing the activity of the genes for growth 
factors (KGF, FGF). It has been found that UV ra-
diation leads to increased expression of CRH receptor 
(CRH-R1). 
Recent studies have identified the existence of a 
peripheral skin stress response system (equivalent to 
the central HPA axis)11-13. It is well known that pi-
tuitary ACTH stimulates adrenal cortisol and glu-
cocorticoid production. Stress influences cellular and 
humoral immune responses by releasing glucocorti-
coid, catecholamine, and CRH and POMC peptide 
secretion as well as by altering cytokine profiles11,12. 
Accordingly, the skin would be a peripheral neuroen-
docrine organ, and local homeostasis is regulated 
through hormones, neurotransmitters, neuropeptides, 
cytokines and their receptors11-15. Also, the presence of 
CRH, urocortin, POMC-derived peptides and their 
receptors is proven in normal skin: in the epidermis, 
hair follicles, blood vessel walls, etc. Thus, HPA axis 
activation at the central, hypothalamic level is stimu-
lated by hormones in the skin, which are a product of 
various cellular elements2. 
POMC is a significant hypophyseal hormone 
(also found in the skin and other organs), a precur-
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sor molecule by whose breakdown [by serine proteases 
PC1 and PC2 (prohormone-convertase)] active neu-
ropeptides and neurohormones are created: MSH 
(α-MSH, β-MSH, γ-MSH), ACTH, β-lipotropic 
hormone (β-LPH)) and β-endorphin. These pep-
tides are bound to melanocortin receptors on skin 
cells: MC-1R (binds α-MSH and ACTH) and MC-
2R (selectively binds ACTH). Thus, POMC and its 
dissolution peptides participate in growth regulation 
and differentiation, immunomodulatory activities and 
melanogenesis stimulation, and is found in the skin in 
keratinocytes, melanocytes, DCs and FBLs. The level 
of POMC peptide is low in healthy skin and increased 
in various skin diseases (e.g., AD, melanoma, carcino-
ma). The expression of POMC is increased under the 
influence of proinflammatory cytokines (IL-l, IL-6, 
TNF-α) and UV radiation, and decreased under the 
influence of antiinflammatory cytokine TGF-β2. 
α-MSH is a neuropeptide (13-amino-acid poly-
peptide) derived from POMC and primarily a hy-
pophyseal product (but also synthesized in the skin), 
whose immune-modulating activity seems to inhibit 
skin inflammation. Thus, α-MSH modulates inflam-
matory and immune response (by anti-inflammatory 
action), and it increases the secretion of anti-inflam-
matory cytokines (IL-10), suppresses the secretion of 
proinflammatory cytokines (IL-l, IL-6, TNF-α) and 
limits antigen presentation (decreases expression of 
MHC-1 and co-stimulatory molecules on DCs). 
The skin can also release α-MSH during the pro-
cess of synthesis and release of POMC, its derivatives 
and a series of other substances [substance P (SP), 
calcitonin gene-related peptide, vasoactive intestinal 
peptide (VIP), neuropeptide Y (NPY), etc.]1. Skin 
cells and Aδ and C nerve fibers release neuropep-
tides that link the nervous system and the skin itself. 
Furthermore, α-MSH may regulate the expression 
of cell mediators on the surface of immune cells and 
decrease IFN-γ release from activated lymphocytes. 
α-MSH also seems to interfere with leukocyte mi-
gration from blood to the sites of inflammation, 
modifying the expression of leukocyte and endothe-
lial adhesion molecules and endothelial leukocyte 
and vascular cell adhesion molecules-1 (VCAM-1). 
Thus, α-MSH and other neuropeptides may func-
tion as a potential therapeutic, anti-inflammatory 
agent in dermatology.
The Role of Corticotropin-Releasing Hormone
Stress activates several neural pathways, but the 
main stress response systems are the locus caeruleus, 
sympathetic-adrenal-medullary system, and HPA 
axis12-16. The stressors stimulate the paraventricular 
nuclei of the hypothalamus, whereas the corticotro-
pin-releasing hormone (CRH) and arginine vasopres-
sin (AVP) are synthesized. Thus, CRH stimulates the 
secretion of AVP (which has a synergistic effect with 
CRH), particularly under chronic stress, while pitu-
itary ACTH stimulates adrenal cortisol and glucocor-
ticoid production. 
It can be said that the skin is homologous to the 
HPA axis and corresponds in organization to the cen-
tral hypothalamic-hypophyseal axis, CRH-POMC-
ACT13,14. Recently, it has been demonstrated that 
dermal FBLs respond to CRH by activating the gene 
for POMC, and subsequently by secreting ACTH2. 
Thus, FBLs demonstrate a functional CRH-POMC-
ACTH-corticosterone axis similar to the hypothala-
mus-hypophysis-adrenal gland axis (systemic response 
to stress), except that FBLs synthesize corticosterone 
(instead of cortisol). In contrast to FBLs, keratino-
cytes do not respond to ACTH by secreting corticos-
terone, although they express CRH–R1 and the gene 
for POMC (they do not demonstrate a functional 
CRH-POMC axis). 
Normal skin expresses CRH, urocortin, POMC-
derived peptides and their receptors. Various skin 
cells can secrete CRH (including epidermal and hair 
follicle keratinocytes, sebocytes and mast cells), and 
melanocytes and FBLs response to local CRH stimu-
lation, confirming the presence of a functional local 
HPA axis12-16. Local production of stress hormones of 
the HPA axis enables the skin to regulate local ho-
meostasis under stress. 
CRH acts through CRH receptor (CRH-R), which 
belongs to the calcitonin/VIP/growth hormone-re-
leasing hormone subfamily of the G protein-coupled 
receptors. These include CRH-R1 (the major recep-
tor in the epidermis and dermis) and CRH-R2 (the 
predominant type of receptor in adnexal structures)17. 
CRH has a different skin effect, i.e. stimulates diverse 
signaling pathways (via CRH-R1 activation), which 
modulate proliferation, differentiation, apoptosis and 
pro- or anti-inflammatory activities of skin cells18.
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CRH activates various skin cells to release the 
proinflammatory cytokines (e.g., IL-6 release by ke-
ratinocytes and IL-1β release by monocytes). As skin 
mast cells function as ‘sensors’ of environmental and 
emotional stress, their CRH-induced activation may 
be associated with exacerbation of skin diseases12,19. 
CRH and urocortin activate skin mast cells (through 
activation of CRH-R1) and increase mast cell’s se-
lective release of vascular endothelial growth factor 
(VEGF) and IL-6 (vascular permeability)19. More-
over, human mast cells can produce CRH and uro-
cortin. 
It could also be mentioned that local concentration 
of neuropeptides and some chemokines is adjusted by 
peptidases on skin cell membranes. Some peptidases 
are expressed on mastocytes, e.g., the neutral pepti-
dase (NEP; CD10), which regulates the concentra-
tion of several neuropeptides (substance P, VIP and 
bradykinin), and adjusts the concentration of opioid 
peptides Len-enkephalins and Met-enkephalins2. 
Hence, CRH has anti-inflammatory activity and 
diminishes NF-kB activation in epidermal melano-
cytes and inhibits IL-18 expression [through the 
mitogen-activated protein kinase (MAPK) signaling 
pathway] in human HaCaT keratinocytes (cell type 
belonging to an immortal human keratinocyte line 
used in scientific research)20. ACTH stimulates hu-
man keratinocytes to secrete IL-18 through melano-
cortin receptors (MC1R and MC2R), p38 and ERK 
MAPK pathways. Since CRH inhibits IL-18 expres-
sion in HaCaT cells, IL-18 may play an important role 
in the negative feedback loop of CRH regulation21. 
The Influence of Psychosocial and Psychiatric 
Factors on Dermatologic Diseases 
Only a few clinical and experimental studies have 
investigated the association of psychoneuroimmunol-
ogy and skin diseases (psoriasis, AD, urticaria, vi-
ral warts, herpes simplex, vitiligo, acnes, itch, etc.). 
However, the majority of observations are limited to 
comparison of clinical pictures of skin diseases and 
psychological states. 
It has been observed that psoriasis is worsened 
by stress, but there is no clear evidence defining the 
exact pathomechanisms1. Many psoriatic patients be-
lieve that there is a causal relationship between stres-
sors and their disease outcome. Earlier studies have 
suggested that exacerbation of psoriasis occurs a few 
weeks to months after a stressful event, which might 
be related to the alteration of the HPA axis and the 
release of neuropeptides12,22. Thus, a recent prospec-
tive study demonstrated a positive significant corre-
lation between preceding daily stressors and clinical 
pictures (Psoriasis Area and Severity Index) and itch 
(4 weeks later)23.
Earlier studies found a hyporesponsiveness of 
HPA axis function in psoriatic patients during expo-
sure to an acute stressor, which might result in exag-
gerated clinical picture due to diminished suppressive 
effect of the low level of cortisol (indicating they are 
more vulnerable to the influence of stressors)12. Recent 
data revealed associations between daily stressors and 
an increase in disease severity a month later, with a 
significant association between the highest levels of 
daily stressors and a lower cortisol level. Schmid-Ott 
et al. proved that after a psychosocial stress, psoriatic 
patients showed an increased number of activated T 
cells with a shift towards Th1-cytokines and an in-
creased number of cutaneous lymphocyte-associated 
antigen-positive T cells and natural killer (NK) cells 
(relevant in aggravation of psoriatic plaques)24. How-
ever, other studies demonstrated no alteration of the 
HPA axis function in psoriasis, indicating that the 
systemic HPA axis response could be normal in a 
Th1-dominant inflammatory condition12,25. 
It is interesting to observe the role of β-endorphin 
(one of the POMC-related peptides) in psoriasis, 
which is produced by the HPA axis or secreted by im-
mune cells. Psoriatic patients with actively spreading 
plaque lesions showed increased serum β-endorphin 
and high lesional β-endorphin, which might induce 
SP-mediated neurogenic inflammation and has an an-
ti-nociceptive effect on peripheral sensory nerve func-
tion (possibly responsible for the absence of itching). 
It is supposed that β-endorphin may be produced by 
lesional inflammatory cells rather than by the activa-
tion of HPA axis in chronic stress12. 
Many researchers focus on the proinflammatory 
role of CRH in psoriasis. So, CRH may activate mast 
cells (via CRH-R), leading to the release of histamine 
with increased vascular permeability. Simultaneously, 
mast cells secrete the proinflammatory cytokines IL-
1, IL-6 and TNF-α (up-regulated in psoriatic skin), 
which are potent stimulators of CRH and POMC 
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production in the skin. In psoriasis, increased serum 
CRH and decreased lesional CRH/CRH-R1 gene ex-
pression suggest that down-regulated lesional CRH/
CRH-R1 expression in psoriatic lesions may be the 
result of negative feedback of systemic CRH eleva-
tion. Thereby, CRH might have a protective function 
from developing psoriatic lesions12. 
However, there are also some conflicting results of 
peripheral HPA axis expression in psoriatic lesions12,18. 
The exposure to stressors (real life and experimental) 
showed dysregulated HPA activity, which might re-
sult in changes of immune responses and peripheral 
CRH levels. Inflammatory mediators released from 
psoriatic lesions interact with peripheral HPA axis and 
may influence the central HPA axis, which should be 
studied further12,26. 
Concerning AD, a chronic allergic skin disease, 
psychological aspects of the disease must also be tak-
en into account. Investigations have revealed that in 
AD patients psychological factors seemed to increase 
serum IFN-γ and IL-4, whereas NK activity was 
decreased mainly by anxiety (not by psychosomatic 
complaints)1.
The studies also suggest that psychological stress 
triggers and aggravates AD by involving the activa-
tion of the HPA axis and inducing a shift toward Th2 
cell phenotype12. After stress, AD patients showed 
blunted HPA axis responsiveness and increased reac-
tivity of the sympathetic adrenomedullary system27. 
Interestingly, neonates with a parental atopic histo-
ry and elevated cord IgE had significantly increased 
HPA responsiveness to the stress of heel prick (pos-
sibly due to hormonal effect to maternal stress), which 
may increase the vulnerability to develop AD later in 
life. Additionally, adolescents with AD had an atten-
uated cortisol response to laboratory stress. However, 
Afsar et al. identified that AD children did not differ 
in basal cortisol levels or anxiety compared with nor-
mal children28. 
There is also an influence of stress-induced CRH 
on the immune response and DCs which promote al-
lergic responses by inducing Th2 cell differentiation. 
So, Lee et al. detected CRH-R1α, 1β, 2α mRNA 
and CRH-R1, CRH-R2 protein in mononuclear cell-
derived DCs in AD patients and revealed that CRH 
significantly decreased the expression of IL-18 in 
DCs29,30. In AD patients, stress-induced CRH may 
enhance Th2 immune responses by acting directly 
on DCs (via CRH-R) and may aggravate the dis-
ease29,30.
Additionally, patients with severe AD have in-
creased serum levels of β-endorphin produced from 
lesional inflammatory cells (rather than by activation 
of central HPA axis in chronic stress). Thereby, stress-
related pruritus may be associated with a systemic 
pruritic effect of β-endorphin29,31,32. It has been found 
that exercise-induced stress differently affects the AD 
symptoms and POMC-related hormone level, de-
pending on the strength of exercise. As β-endorphin 
strengthens natural immunity, proper exercise might 
be helpful to control the AD symptoms by stimulat-
ing the HPA axis and inducing balanced Th1/Th2 
immunity. 
Exacerbation of AD due to stress also manifests 
through mast cell activation29. In the presence of stem 
cell factor (SCF) and IL-4, mast cells produce mostly 
Th2-cytokines and release neuropeptides (such as SP 
and nerve growth factor, NGF)19. Experimental stress 
in AD patients also stimulates enhanced allergen-spe-
cific immune responses with elevated levels of plasma 
SP, VIP and NGF, and concomitant increase of Th2-
cytokines33. There are few studies about local stress 
hormone expression in AD lesions. The neuropeptides 
NGF and NPY are known to be associated with anxi-
ety (anxiety score positively correlated with pruritus 
in AD patients)33. According to study results, the epi-
dermis of AD skin lesions showed significantly higher 
NGF and NPY expression, indicating that they par-
ticipate in the activation of intraepidermal mast cells, 
contributing to stress-induced pruritus34,35. 
AD patients also showed blunted HPA axis re-
sponses to stressors. In general, stress negatively af-
fects the severity of AD by down-regulating cellular 
immunity and enhancing humoral immunity. Thus, 
CRH and POMC-related peptide hormones, as well 
as the neuropeptides SP, NGF and NPY modulate im-
mune and inflammatory response under stress. How-
ever, psychological interventions have been shown to 
have positive effects on skin status, itch and scratch-
ing behavior in patients36.
Regarding urticaria, it has also been indicated that 
psychological factors may contribute to its occurrence, 
especially in chronic urticaria. Psychosocial and psy-
chiatric factors may act in the pathogenesis of urti-
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caria, mostly by increasing the release of neuro- and 
immune mediators, mainly from mast cells (e.g., IL-4, 
IL-5, IFN-γ, and TNF-α) and the release of vasoac-
tive peptides (including histamine)1.
There is also evidence of the psychoneuroimmune 
mechanisms in the pathogenesis of vitiligo37. Some 
investigators revealed a higher number of stressful 
life events in these patients compared to controls, as 
well as abnormal secretion of neuromediators (e.g., 
β-endorphin and metenkephalin) and higher immu-
noreactivity to NPY and VIP. Not all effects of neuro-
peptides on melanocytes are known, although nervous 
system seems to play a role in activating melanocytes1. 
Alternatively, clinical and experimental evidence sug-
gests a role of humoral and cellular autoimmunity in 
vitiligo pathogenesis. 
It is important to mention that some infective skin 
diseases are also under psychological influence (e.g., 
viral warts, herpes simplex)38,39.
There are also other dermatologic diseases for 
which there is evidence of psychological and psychi-
atric etiological factors. This indicates its importance 
in considering the possibility that those patients could 
benefit from cognitive behavioral and psychological 
therapy1,40. 
As dermatologists and dermatologic patients have 
long acknowledged the effect of stress on the skin and 
its capability to initiate, maintain, or exacerbate sev-
eral skin diseases, it is important to understand skin 
vulnerability to psychological stress40-42. It is signifi-
cant that stress resistance can be enhanced by per-
sonal coping mechanisms, social support, and favor-
able psychosocial constellations. A multidisciplinary 
approach for treatment from both dermatologic and 
psychiatric viewpoints is suggested. 
Conclusion
The link between emotional stressors (acute or 
chronic), psychiatric diseases, and dermatoses (e.g., 
psoriasis, AD, urticaria, viral warts, herpes simplex, 
vitiligo, acnes, alopecia, prurigo, etc.) has been evi-
denced. Thereby, different cytokines, mediators and 
hormones are produced in the skin and involved in the 
pathogenesis of these skin disorders. A prominent role 
is played by those agents that belong to the HPA axis 
and there is plenty of evidence that the skin includes 
a neuroendocrine control mechanism similar to the 
central one. This indicates its importance in consid-
ering the possibility that these patients could benefit 
from cognitive behavioral and psychological therapy 
or other therapeutic methods. However, the psycho-
logical and psychiatric genesis of a skin disease is still 
a topic of investigation.
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Sažetak
PSIHONEUROIMUNOLOŠKI ASPEKTI KOŽNIH BOLESTI
L. Lugović-Mihić, L. Ljubešić, J. Mihić, V. Vuković-Cvetković, N. Troskot i M. Šitum 
S obzirom na to da su mentalne i psihološke značajke važne u razvoju mnogih dermatoloških bolesti, ovi čimbenici 
su od posebnog interesa za istraživanja. Psihoneuroimunologija obuhvaća međudjelovanje psiholoških procesa, živčanog 
i imunog sustava te ljudskog tijela, a prvi put je jasno opisana prije oko 30 godina. Komunikacija između psihe i kože 
uključuje psihološki-imuni-endokrini-kožni sustav obuhvaćajući aktivnosti mozga, imunog sustava i kože, uza sudjelova-
nje različitih neuropeptida, interleukina i posrednika imunog sustava. Mnoge česte dermatološke bolesti imaju neki oblik 
psihološki uvjetovane patogeneze koja dijelom doprinosi razvoju kožnih promjena. Pritom postoji veza između emocio-
nalnih stresora (akutnih ili kroničnih), psihijatrijskih bolesti i dermatoza (npr. psorijaza, atopijski dermatitis, urtikarija, 
akne, virusne bradavice, herpes simpleks, vitiligo, alopecia, prurigo itd.) te različitih citokina i medijatora stvorenih u koži 
koji su uključeni u njihovu patogenezu. Istaknutu ulogu imaju tvari koje pripadaju osi hipotalamus-hipofiza-nadbubrežna 
žlijezda. 
Ključne riječi: Psihoneuroimunologija; Koža; Kožne bolesti; Interleukini; Neuropeptidi; Hormoni
